← Leaderboards
Christiana Nicole Teijaro
Scripps Florida
$155,104
Attributed
$155,104
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $65.3K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$155,104 · 1
By mechanism
F32$155,104 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Florida
Same institution · by research overlap
- Jeffrey Daniel Rudolf$2,787,115
- Andrew Steele$195,098
- Robert Edward Kalkreuter$192,170
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogAntibodiesAntibody-Drug ConjugatesAntibody EngineeringAnti-Cancer TherapeuticAntigen TargetingAreaBaseBenchmarkingBeta-LactamsBinding SitesBiochemicalBreast Cancer CellBreast Cancer Cell LineBreast Cancer TherapyBreast Cancer TreatmentCancer TherapyCancer TypeCell TypeCessation Of LifeChemistryClinical TrialsCysteineAnabolism
Grant awards (3)
Novel Tiancimycins (TNMs) Antibody Drug Conjugates (ADCs) for Anticancer Therapeutics$28,568
F32 · FY2021 · GM · contact PI
Novel Tiancimycins (TNMs) Antibody Drug Conjugates (ADCs) for Anticancer Therapeutics$65,310
F32 · FY2020 · GM · contact PI
Novel Tiancimycins (TNMs) Antibody Drug Conjugates (ADCs) for Anticancer Therapeutics$61,226
F32 · FY2019 · GM · contact PI